May 1, 2020
Teva Ajovy Injection and Austedo, new data
23 abstracts appeared in the 2020 American Academy of Neurology (AAN) Science Highlights Supplement TEL AVIV & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Ajovy
April 27, 2020
– Teva launches autoinjector for Ajovy injection in USA
Teva Pharmaceuticals USA, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the autoinjector device for AJOVY® (fremanezumab-vfrm) injection is now available in the U.S.
April 1, 2019
Teva’s AJOVY® Receives EU Approval Offering Patients the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Prophylaxis of Migraine in Adults
In clinical trials, many patients on AJOVY experienced significant reductions of at least 50% in the number of monthly migraine…